By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – British molecular diagnostics firm Osmetech has filed with the US Securities and Exchange Commission for an initial public offering of stock in the US under the name of its newly proposed parent, GenMark Diagnostics.
Registering provides access to this and other free content.
Already have an account?Login Now.
The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.
Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.
In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.
Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.